Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Clinical trial NCT03788967 · COMPLETED
Trial details
- NCT number
- NCT03788967
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-05-20
- Enrollment
- 1372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.